Nakamichi, S., Nokihara, H., Yamamoto, N., Yamada, Y., Honda, K., Tamura, Y., . . . Tamura, T. (2015). A phase 1 study of lenvatinib, multiple receptor tyrosine kinase inhibitor, in Japanese patients with advanced solid tumors. Cancer Chemother Pharmacol.
Chicago Style citaatNakamichi, Shinji, et al. "A Phase 1 Study of Lenvatinib, Multiple Receptor Tyrosine Kinase Inhibitor, in Japanese Patients With Advanced Solid Tumors." Cancer Chemother Pharmacol 2015.
MLA citatieNakamichi, Shinji, et al. "A Phase 1 Study of Lenvatinib, Multiple Receptor Tyrosine Kinase Inhibitor, in Japanese Patients With Advanced Solid Tumors." Cancer Chemother Pharmacol 2015.
Let op: Deze citaties zijn niet altijd 100% accuraat.